WE ARE LIFE SCIENCES.
Your Partner in Life Sciences Insurance
In the pioneering world of life sciences, you need deep expertise and trusted guidance to protect your innovation. As a pure-play insurance partner with multinational capabilities, our experts help you navigate complexity and customize solutions that meet your unique insurance needs.
For us, life sciences insurance is not just another vertical; it is our sole obsession.
Protecting Tomorrow's Innovations, Together
Scientific breakthroughs are fragile. From the first spark of an idea in a university lab to a global clinical trial, innovation faces challenges: regulatory hurdles, funding gaps, and complex operational risks.
Our role is simple but vital - to help ensure that manageable risks do not derail life-saving innovation. We don't just protect balance sheets; we partner with the innovators of tomorrow to safeguard the future of health.
A Smarter Way to Approach Insurance
Specialized Expertise That Grows as You Grow
Whether you are preclinical, clinical, or commercial, U.S. or global, our experienced specialists help you navigate complexity and find solutions to even the most unique risks.
Partners in Progress
As a member of the life sciences community, we deeply understand your challenges and champion your progress, especially when the stakes are high.
Purpose-Built for the Pace of Innovation
As an innovator, you need insights and outcomes you can trust, at a pace that keeps up with your momentum. With Berkley Life Sciences, you get a partner who works with agility and autonomy backed by the W. R. Berkley Corporation, a Fortune 500 powerhouse.
In-House Claims
From the start of the underwriting process, our in-house claims team is a true partner in your insurance experience. With extensive life science products liability claim and litigation expertise, our claims team collaborates with insureds, brokers, and our defense counsel to actively lead claims to just resolution.
The Latest in Life Science
Hearing the Full Orchestra: Multiomics, AI, and the Future of Therapeutic Discovery
A genome can reveal the biological instructions a person inherited. It cannot, by itself, show which instructions are active, how much protein a cell is producing, or how disease, treatment, environment, and time are altering those processes.
A Decade After the Ice Bucket Challenge: Progress in ALS Research
More than a decade after millions of people, from movie stars and athletes to everyday individuals, dumped ice water over their heads in support of amyotrophic lateral sclerosis (ALS), the movement’s long-term impact on research, care, and public awareness is becoming clear.
Beyond the Label: Will FDA’s ACNU Framework Transform Nonprescription Access?
Imagine walking into your local pharmacy without a prescription and purchasing a medication that traditionally required one after completing a questionnaire or similar screening process. Medications that previously depended on practitioner involvement could become more accessible if consumers successfully complete safeguards approved by the Food and Drug Administration (FDA). That possibility is at the center of FDA’s Additional Condition for Nonprescription Use (ACNU) framework.